Erez Raphael - DarioHealth Corp Insider

DRIO -- USA Stock  

USD 1.36  0.01  0.74%

Chairman, CEO and Pres
Mr. Erez Raphael is Chief Executive Officer, Director of the Company. He has served as our Chief Executive Officer since August 9, 2013 and as a director of our Company since December 2013. Mr. Raphael has served as Chairman of the Board of Directors since November 2014. He previously and since October 2012 served as our Vice President of Research and Development. Mr. Raphael has over 17 years of industry experience, having been responsible in his career for product delivery, technology and business development. Prior to joining us, from 2010 to 2012, Mr. Raphael served as Head of Business Operations for Nokia Siemens Networks, where he was responsible for establishing and implementing a new portfolio business unit directed towards marketing and sales of complimentary products. Prior to that, from 1998 to 2010, he held increasingly senior positions at Amdocs Limited where he was ultimately responsible for advising the Chief Technology Officer and implementing matters of overall business strategy
Age: 43  Chairman Since 2018      
972 4 770 4055
Raphael holds a B.A. in economics and business management from Haifa University. We believe Mr. Raphael is qualified to serve on our Board because of his extensive experience with technology companies and in sales and marketing.

Erez Raphael Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (103.78) % which means that it has lost $103.78 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (249.89) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Entity Summary

DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. DarioHealth Corp. was founded in 2011 and is headquartered in Caesarea, Israel. DarioHealth Corp operates under Diagnostics Research classification in USA and traded on Nasdaq Capital Markets. It employs 45 people.DarioHealth Corp (DRIO) is traded on BATS Exchange in USA. It is located in ISRAEL and employs 45 people. DarioHealth Corp was previously known as DarioHealth Corp Warrant and was traded on BATS Exchange under the symbol DRIOW. DarioHealth Corp is listed under Medical Equipment category by Fama And French industry classification.

DarioHealth Corp Leadership Team

Rami Yehudiha, Director, MBA
Hila Karah, Director
Yossi Bahagon, Director
Yoav Shaked, Chairman
Dror Bacher, COO, MBA
Zvi BenDavid, CFO
Yalon Farhi, Director
Erez Raphael, Chairman
Ori Zanco, Director, MBA
Allen Kamer, Director
Dennis McGrath, Director
Malcolm Hoenlein, Director
Richard Stone, Director

Stock Performance Indicators

Did you try this?

Run Portfolio Suggestion Now

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Portfolio Suggestion

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for DarioHealth Corp and Agilent Technologies. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see Investing Opportunities. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.